Cargando…

Double-Dosing and Other Dangers with Non-Prescription Medicines: Pharmacists’ Views and Experiences

The aim of this paper was to explore pharmacists’ views on reclassifications from pharmacy-only to general sales and their experiences with the supply of these medicines, in addition to pharmacists’ views on the reclassification of the shingles vaccine and sildenafil to be available through ‘accredi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gauld, Natalie, Sullivan, Tracey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165278/
https://www.ncbi.nlm.nih.gov/pubmed/30004399
http://dx.doi.org/10.3390/pharmacy6030059
_version_ 1783359799183802368
author Gauld, Natalie
Sullivan, Tracey
author_facet Gauld, Natalie
Sullivan, Tracey
author_sort Gauld, Natalie
collection PubMed
description The aim of this paper was to explore pharmacists’ views on reclassifications from pharmacy-only to general sales and their experiences with the supply of these medicines, in addition to pharmacists’ views on the reclassification of the shingles vaccine and sildenafil to be available through ‘accredited’ pharmacists. New Zealand community pharmacists were surveyed in 2013 with a written questionnaire of six Likert-style or open-ended questions sent to Pharmacy Guild member pharmacies. The analysis involved descriptive statistics. Responses were received from 246 pharmacies. Two thirds of pharmacists supported the reclassification of the shingles vaccine and sildenafil, although 14% disagreed with the sildenafil reclassification. Over 90% of pharmacists disagreed with the reclassification of paracetamol and ibuprofen liquids, omeprazole, naproxen, and oxymetazoline from pharmacy-only medicine to general sales. This opinion was strongest for omeprazole. With liquid paracetamol and ibuprofen, pharmacists described consumer confusion with dosing, and particularly potentially doubling-up on liquid analgesics/antipyretics including using both prescription and non-prescription variants. Many reported giving safety advice frequently. Anti-inflammatories and omeprazole were also subject to potential double-dosing, as well as requests by consumers with contraindications, precautions, and drug interactions, and for inappropriate indications. Pharmacists described various interventions, including some that were potentially life-saving. Pharmacy availability of medicines provides the potential for intervention that would not happen in a general sales environment.
format Online
Article
Text
id pubmed-6165278
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61652782018-10-10 Double-Dosing and Other Dangers with Non-Prescription Medicines: Pharmacists’ Views and Experiences Gauld, Natalie Sullivan, Tracey Pharmacy (Basel) Article The aim of this paper was to explore pharmacists’ views on reclassifications from pharmacy-only to general sales and their experiences with the supply of these medicines, in addition to pharmacists’ views on the reclassification of the shingles vaccine and sildenafil to be available through ‘accredited’ pharmacists. New Zealand community pharmacists were surveyed in 2013 with a written questionnaire of six Likert-style or open-ended questions sent to Pharmacy Guild member pharmacies. The analysis involved descriptive statistics. Responses were received from 246 pharmacies. Two thirds of pharmacists supported the reclassification of the shingles vaccine and sildenafil, although 14% disagreed with the sildenafil reclassification. Over 90% of pharmacists disagreed with the reclassification of paracetamol and ibuprofen liquids, omeprazole, naproxen, and oxymetazoline from pharmacy-only medicine to general sales. This opinion was strongest for omeprazole. With liquid paracetamol and ibuprofen, pharmacists described consumer confusion with dosing, and particularly potentially doubling-up on liquid analgesics/antipyretics including using both prescription and non-prescription variants. Many reported giving safety advice frequently. Anti-inflammatories and omeprazole were also subject to potential double-dosing, as well as requests by consumers with contraindications, precautions, and drug interactions, and for inappropriate indications. Pharmacists described various interventions, including some that were potentially life-saving. Pharmacy availability of medicines provides the potential for intervention that would not happen in a general sales environment. MDPI 2018-07-02 /pmc/articles/PMC6165278/ /pubmed/30004399 http://dx.doi.org/10.3390/pharmacy6030059 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gauld, Natalie
Sullivan, Tracey
Double-Dosing and Other Dangers with Non-Prescription Medicines: Pharmacists’ Views and Experiences
title Double-Dosing and Other Dangers with Non-Prescription Medicines: Pharmacists’ Views and Experiences
title_full Double-Dosing and Other Dangers with Non-Prescription Medicines: Pharmacists’ Views and Experiences
title_fullStr Double-Dosing and Other Dangers with Non-Prescription Medicines: Pharmacists’ Views and Experiences
title_full_unstemmed Double-Dosing and Other Dangers with Non-Prescription Medicines: Pharmacists’ Views and Experiences
title_short Double-Dosing and Other Dangers with Non-Prescription Medicines: Pharmacists’ Views and Experiences
title_sort double-dosing and other dangers with non-prescription medicines: pharmacists’ views and experiences
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165278/
https://www.ncbi.nlm.nih.gov/pubmed/30004399
http://dx.doi.org/10.3390/pharmacy6030059
work_keys_str_mv AT gauldnatalie doubledosingandotherdangerswithnonprescriptionmedicinespharmacistsviewsandexperiences
AT sullivantracey doubledosingandotherdangerswithnonprescriptionmedicinespharmacistsviewsandexperiences